1. Home
  2. GKOS vs BFAM Comparison

GKOS vs BFAM Comparison

Compare GKOS & BFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • BFAM
  • Stock Information
  • Founded
  • GKOS 1998
  • BFAM 1986
  • Country
  • GKOS United States
  • BFAM United States
  • Employees
  • GKOS N/A
  • BFAM N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • BFAM Other Consumer Services
  • Sector
  • GKOS Health Care
  • BFAM Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • BFAM Nasdaq
  • Market Cap
  • GKOS 5.4B
  • BFAM 5.7B
  • IPO Year
  • GKOS 2015
  • BFAM 1997
  • Fundamental
  • Price
  • GKOS $87.64
  • BFAM $100.45
  • Analyst Decision
  • GKOS Strong Buy
  • BFAM Buy
  • Analyst Count
  • GKOS 13
  • BFAM 7
  • Target Price
  • GKOS $120.38
  • BFAM $132.57
  • AVG Volume (30 Days)
  • GKOS 718.5K
  • BFAM 591.2K
  • Earning Date
  • GKOS 10-29-2025
  • BFAM 10-30-2025
  • Dividend Yield
  • GKOS N/A
  • BFAM N/A
  • EPS Growth
  • GKOS N/A
  • BFAM 75.19
  • EPS
  • GKOS N/A
  • BFAM 3.05
  • Revenue
  • GKOS $432,953,000.00
  • BFAM $2,790,342,000.00
  • Revenue This Year
  • GKOS $28.90
  • BFAM $10.42
  • Revenue Next Year
  • GKOS $25.57
  • BFAM $7.11
  • P/E Ratio
  • GKOS N/A
  • BFAM $32.99
  • Revenue Growth
  • GKOS 26.70
  • BFAM 9.24
  • 52 Week Low
  • GKOS $77.10
  • BFAM $95.53
  • 52 Week High
  • GKOS $163.71
  • BFAM $135.78
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 53.74
  • BFAM 36.70
  • Support Level
  • GKOS $82.19
  • BFAM $96.06
  • Resistance Level
  • GKOS $86.74
  • BFAM $101.41
  • Average True Range (ATR)
  • GKOS 3.27
  • BFAM 2.41
  • MACD
  • GKOS 0.56
  • BFAM 0.10
  • Stochastic Oscillator
  • GKOS 82.87
  • BFAM 35.63

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; full-service center-based child care, backup care, and educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.

Share on Social Networks: